Citurgia Biochemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve audited Financial Results ....
Awaiting price reaction for this filing.
Citurgia Biochemicals has informed BSE that its Board of Directors meeting is scheduled for May 30, 2026. The meeting will consider and approve the audited financial results for the quarter and full year ended March 31, 2026. The company has also confirmed that the trading window for insiders remains closed from April 1, 2026 and will reopen 48 hours after the results are declared. This is a routine regulatory intimation under SEBI LODR regulations and does not provide any indication of the financial performance or outcomes.
This is a standard meeting notice with no indication of financial performance. The actual impact on shareholders will depend on the financial results declared at this meeting. The closed trading window indicates insider awareness of upcoming material information.